Jeffrey W. Sherman - 06 Apr 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP and Chief Medical Officer
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
06 Apr 2022
Net transactions value
-$4,621,872
Form type
4
Filing time
08 Apr 2022, 16:07:51 UTC
Previous filing
21 Mar 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Sale $4,621,872 -42,009 -80% $110.02 10,629 06 Apr 2022 Direct F1, F2
holding HZNP Ordinary Shares 52,944 06 Apr 2022 See footnote F3
holding HZNP Ordinary Shares 66,730 06 Apr 2022 By Spouse
holding HZNP Ordinary Shares 105,808 06 Apr 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2021.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The shares are held in the Jeffrey W. Sherman Living Trust.
F4 The shares are held in the name of the Jeffrey W. Sherman 2020 Gift Trust, of which the reporting person's spouse is the Trustee.